Assess Fibrin in Brains With AD/ADRD
Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET
Massachusetts General Hospital
30 participants
Mar 29, 2022
INTERVENTIONAL
Conditions
Summary
The goal of this project is to quantify brain fibrin content using 64Cu-FBP8-PET in the brains of subjects ranging from cognitively normal to clinically diagnosed with ADRD to evaluate potential regional differences.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PET/MRI Scan with \[64Cu\]FBP8 as directed by protocol
Will be administered by intravenous injection by bolus by a qualified nuclear medicine technician at the Martinos Center
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05336695